Univ. of Mississippi Medical Center (UMMC)
Welcome,         Profile    Billing    Logout  
 5 Trials 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wright, Patrick
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

Completed
3
214
US
Open-label pitolisant, Double-blind placebo, Double-blind pitolisant
Harmony Biosciences, LLC
Idiopathic Hypersomnia
09/23
09/23
NCT04296903: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Active, not recruiting
N/A
200
US
MID-C System
Apifix
Adolescent Idiopathic Scoliosis
06/29
06/30
Jobanputra, Amishi
NCT04296903: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Active, not recruiting
N/A
200
US
MID-C System
Apifix
Adolescent Idiopathic Scoliosis
06/29
06/30
Bhanat, Eldrin
NCT04296903: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Active, not recruiting
N/A
200
US
MID-C System
Apifix
Adolescent Idiopathic Scoliosis
06/29
06/30
Chan, Gilbert
NCT04296903: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Active, not recruiting
N/A
200
US
MID-C System
Apifix
Adolescent Idiopathic Scoliosis
06/29
06/30
Brooks, Jaysson
NCT04296903: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Active, not recruiting
N/A
200
US
MID-C System
Apifix
Adolescent Idiopathic Scoliosis
06/29
06/30
Sukkarieh, Hamdi
NCT04296903: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Active, not recruiting
N/A
200
US
MID-C System
Apifix
Adolescent Idiopathic Scoliosis
06/29
06/30
Nehete, Priyanka
NCT04296903: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Active, not recruiting
N/A
200
US
MID-C System
Apifix
Adolescent Idiopathic Scoliosis
06/29
06/30

Download Options